Skip to main content
. 2019 Feb 5;6(3):227–234. doi: 10.1002/mdc3.12728

Table 2.

Acceptability parameters of the preliminary Movement Disorder Society‐Non‐Motor Symptoms scale

Parkinson's disease patients Healthy controls
Floor effect (%) Ceiling effect (%) Skewness Floor effect (%) Ceiling effect (%) Skewness
A. Depression 29.0** 0 2.67 68.4 0 2.85
B. Anxiety 27.5* 0 2.36 52.6 0 3.63
C. Apathy 39.1*** 0 2.64 89.5 0 2.92
D. Psychosis 76.5 0 3.21 89.5 0 2.80
E. ICD & related disorders 79.7 0 3.43 89.5 0 3.48
F. Other NPS 53.6 0 3.49 52.6 0 1.93
G. Cognition 18.8 0 1.89 36.8 0 2.63
H. Orthostasis 55.1* 0 2.16 84.2 0 3.31
I. Urinary 33.3** 0 1.95 68.4 0 4.22
J. Sexual 61.2* 4.5 2.45 63.2 0 3.84
K. Gastrointestinal 31.9* 0 4.21 63.2 0 2.03
L. Thermoregulatory 55.1 1.5 2.24 73.7 0 3.38
M. Sleep & wakefulness 7.3** 0 2.57 31.6 0 3.14
N. Pain 34.8* 0 1.82 63.2 0 3.19
O. Others 22.1*** 0 2.53 78.9 0 4.18
MDS‐NMS total 0** 0 2.43 10.5 0 2.17
P. Non‐motor fluctuations 51.0*** 2.0 4.64 ‐‐ ‐‐ ‐‐

Abbreviations: MDS‐NMS, Movement Disorder Society‐Non‐Motor Symptoms scale.

Statistically significant difference between patients and controls for floor effect:

*p < 0.05; **p < 0.01; ***p < 0.001.

The rest of differences was not significant.